Revised FDA labeling guideline for theophylline oral dosage forms.
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000628:Aminophylline / Q000737:chemistry; D001993:Bronchodilator Agents / Q000737:chemistry; D002648:Child; D002675:Child, Preschool; D002794:Choline / Q000031:analogs & derivatives / Q000737:chemistry; D004347:Drug Interactions; D004348:Drug Labeling / Q000331:legislation & jurisprudence*; D062787:Drug Overdose / Q000628:therapy; D006801:Humans; D007223:Infant; D013806:Theophylline / Q000031:analogs & derivatives / Q000737:chemistry / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000506:poisoning; D014481:United States; D014486:United States Food and Drug Administration
D001993:Bronchodilator Agents; D000628:Aminophylline; C012839:cholinophyllin; D013806:Theophylline; D002794:Choline